Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Edits on 4 Jan, 2024

"Created via: Clinical trial importer"

created this topic on 4 Jan, 2024

Edits made to:

Infobox (+14 properties)

Article (+154 characters)

‌

Article

Study summary

Patients with chronic HBV infection will receive ARC-520 in combination with entecavir or tenofovir and be evaluated for safety and efficacy.

Infobox

Is a

NCT Number

Trial Recruitment Size

Trial Sponsor

Clinical Trial Start Date

2015

Primary Completion Date

2015

Study Completion Date

2016

Clinical Trial Study Type

Interventional0

Interventional Trial Purpose

Treatment0

Official Website

Last Updated

August 14, 2015

Allocation Type

NA0

Intervention Model

Single Group Assignment0

Masking Type

None (Open Label)0

Find more entities like Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.